Skip to main content
OpenTrials
Enrolling by Invitation

NCT Number: NCT07529041

Real-time Acoustic Biofeedback for Enhancing Fixation Stability: A Proof-of-concept Study to Improve Ophthalmic Imaging Diagnostic Quality

The goal of this Proof of Concept Feasibility Study is to improve the fixation stability in patients with fixation loss due to blindness or central vision loss using a patented acoustic real-time feedback device. The main questions it aims to answer are:

1. Fixation guidance - can real-time acoustic biofeedback improve the fixation in healthy patients as well as patients with fixation loss? 2. Optimization of fixation guidance - testing of different stimuli to optimize an acoustic training protocol. 3. Optimization of imaging acquisition - testing improvement of both imaging quality and acquisition time using the acoustic feedback tool.

For the proof-of-concept-study, patients are asked to fixate on a target point in a darkened room and keep up the fixation. We record patients eye movements with near-infrared-lighting and a camera. Fixation is tested in three conditions - visual target only, auditory feedback only, and visual target followed by auditory feedback. In between each set of trials, patients are asked to rate their subjective exhaustion on a Likert scale. At the end of each recording session, patients are handed a questionnaire for feedback on our proof-of-concept study and device settings.

An ethics-approved extension phase is planned to further optimize device parameters and assess performance in a clinical setting.

Enrolling by Invitation

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

EKFZ Else Kroener Fresenius Center for Optogenetic Therapies, University Medical Center Goettingen

Göttingen, 37075, Germany

About this study

The goal of this Proof of Concept Feasibility Study is to improve the fixation stability in patients with fixation loss due to blindness or central vision loss using a patented acoustic real-time feedback device. The main questions it aims to answer are:

  • Fixation guidance - can real-time acoustic biofeedback improve the fixation in healthy patients as well as patients with fixation loss?
  • Optimization of fixation guidance - testing of different stimuli to optimize an acoustic training protocol.
  • Optimization of imaging acquisition - testing improvement of both imaging quality and acquisition time using the acoustic feedback tool.

Primary endpoints: Fixation stability (in BCEA and distance from target center), fixation duration, time to fixate. We test fixation in two angles: neutral position (0°) and at 15° eccentricity. We compare three conditions: visual target only, combined visual and auditory feedback, and auditory feedback only.

Secondary endpoints: adaptation and training effects over time, exhaustion measured in a Likert scale. We measure changes of pupil diameter in response to acoustic and visual stimuli. We also compare efficacy between healthy subjects and subjects with fixation loss and compare efficacy between the three conditions.

For the proof-of-concept part of our study, patients are asked to fixate on a target point in a darkened room and keep up fixation for 10 seconds. We record patients eye movements with near-infrared-lighting and a camera. There are three blocks for each condition (visual, auditory, combined), each block consists of 10 trials per eye and per angle. In between each set of trials, patients are asked to rate their subjective exhaustion on a Likert scale. At the end of each recording session, we ask patients for their subjective feedback on which condition was easiest to keep up fixation, whether auditory stimuli were sufficient and open-ended questions on potential improvements of the setup.

An ethics-approved extension phase is planned to further optimize device parameters and assess performance in a clinical setting. We validate the findings of our proof-of-concept study and optimize the device settings by adding the acoustic fixation device to our imaging devices. We will compare the results to answer the question whether the acoustic fixation device will lead to an improved imaging quality and acquisition time.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Healthy participants:

  • minimum age of 18 years
  • no neurological or ophthalmological disease
  • ability to perceive auditory feedback
  • normal vision
  • consent to participate in study

Patients:

  • minimum age of 18 years
  • existing ophthalmological diagnosis of fixation deficite or loss
  • ability to perceive auditory feedback
  • consent to participate in study

Exclusion criteria

  • lack of ability to consent to participate in study
  • reduced cooperation during examination or recording
  • inability to perceive auditory feedback
  • age below 18 years
  • patients with nystagmus or inability to move eyes
  • opacity of cornea or other ocular structures preventing successful eye tracking
  • inability to communicate

Treatment and study plan

A device providing acoustic real-time biofeedback

Device

We use a camera and an eye tracking software, linked with our spatial-audio mapping tool. Participants receive real-time audio feedback on the location of their gaze. Negative feedback sounds are encoded to convey distance and direction of the deviation from the center. When the patients fixate on the target area, they receive a positive feedback sound.

Other names: eyeFAST - eye Fixation by Acoustic Stabilization & Tracking

Primary outcomes

  1. Fixation stability - change from baseline fixation stability recorded without acoustic fixation device compared to fixation stability recorded with acoustic fixation device

    Time frame: Day 1

    In Phase A, we analyse the fixation stability as the distance from the target center (Median [IQR]), duration of fixation and time to achieve stable fixation (latency). We also use posthoc video analysis to generate the BCEA as a measure of fixation stability in each condition and each angle (0 and 15 degrees).

Secondary outcomes

  1. Change in time to achieve fixation over repeated trials

    Time frame: Day 1

    Time required to achieve fixation was assessed across repeated trials to evaluate potential training or adaptation effects. We calculate the time to achieve fixation in seconds across 10 trials per eye per condition per angle. We compare the time to fixate in milliseconds of the first half of trials to the second half of trials.

  2. Subjective exhaustion rating (Likert scale, 1-10)

    Time frame: Day 1

    We test the subjective exhaustion of each participant after each recording session. We provide a scale from 1-10 (1 being extremely exhausted, 10 being not exhausted at all) for participants to provide subjecte exhaustion feedback.

  3. Difference in fixation stability (BCEA, time to fixate in ms) between blind and healthy participants across feedback conditions

    Time frame: Day 1

    We compare the efficacy of auditory feedback on fixation stabilty between the healthy and the patient subject group. We also compare the efficacy of the three modalities (combined, auditory and visual) in between groups and within each arm to assess the effect of auditory feedback.

  4. Correlation between pupil diameter change (mm) and fixation stability (BCEA)

    Time frame: Day 1

    Further, we measure the pupil reaction as changes in pupil diameter (mm) over time (seconds) across different feedback conditions (visual, auditory, combined) and correlate those changes with the achieved fixation stability parameter (BCEA).

  5. Comparison of fixation stability with clinical and imaging parameters

    Time frame: Day 1

    We further analyse the correlation between achieved fixation stability and clinical parameters (such as visual acuity, age of disease onset, year of diagnosis, clinical and genetic diagnosis) and imaging parameters (presence of EZ in OCT-Scans, thickness of retinal layers, perfusion density, vascular density of deep, intermediate and superficial retinal vascular plexuses in OCTA), fundus autofluorescence, visual field parameters and ophthalmological examination results.

Sponsors and collaborators

Lead sponsor

University Medical Center Goettingen

Other

Collaborators

  • Else Kröner Fresenius Foundation

Registry information

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Apr 14, 2026
Registry last updated
Apr 14, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.